<VariationArchive VariationID="647" VariationName="NM_000130.5(F5):c.4699_4702dup (p.Ala1568fs)" VariationType="Duplication" Accession="VCV000000647" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2017-08-20" MostRecentSubmission="2017-08-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15686" VariationID="647">
      <GeneList>
        <Gene Symbol="F5" FullName="coagulation factor V" GeneID="2153" HGNC_ID="HGNC:3542" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169511951" stop="169586481" display_start="169511951" display_stop="169586481" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169481191" stop="169555768" display_start="169481191" display_stop="169555768" Strand="-" />
          </Location>
          <OMIM>612309</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000130.5(F5):c.4699_4702dup (p.Ala1568fs)</Name>
      <CanonicalSPDI>NC_000001.11:169540387:CAAT:CAATCAAT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169540387" stop="169540388" display_start="169540387" display_stop="169540388" variantLength="4" positionVCF="169540387" referenceAlleleVCF="G" alternateAlleleVCF="GCAAT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169509625" stop="169509626" display_start="169509625" display_stop="169509626" variantLength="4" positionVCF="169509625" referenceAlleleVCF="G" alternateAlleleVCF="GCAAT" />
      </Location>
      <OtherNameList>
        <Name>F5, 4-BP INS, 2805ATTG</Name>
      </OtherNameList>
      <ProteinChange>A1568fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.169509626_169509629dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.169509626_169509629dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.169540388_169540391dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.169540388_169540391dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011806.1" sequenceAccession="NG_011806" sequenceVersion="1" change="g.51141_51144dup">
            <Expression>NG_011806.1:g.51141_51144dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000130.5" sequenceAccession="NM_000130" sequenceVersion="5" change="c.4699_4702dup" MANESelect="true">
            <Expression>NM_000130.5:c.4699_4702dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000121.2" sequenceAccession="NP_000121" sequenceVersion="2" change="p.Ala1568fs">
            <Expression>NP_000121.2:p.Ala1568fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_553" sequenceAccession="LRG_553">
            <Expression>LRG_553:g.51141_51144dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="612309.0005" DB="OMIM" />
        <XRef Type="rs" ID="773569662" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00006" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000130.5(F5):c.4699_4702dup (p.Ala1568fs) AND Factor V deficiency" Accession="RCV000000681" Version="5">
        <ClassifiedConditionList TraitSetID="169">
          <ClassifiedCondition DB="MedGen" ID="C4317320">Factor V deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1999-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-08-20" MostRecentSubmission="2017-08-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10494770</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="169" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1267" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Factor V deficiency</ElementValue>
                <XRef ID="Factor+V+Deficiency/2709" DB="Genetic Alliance" />
                <XRef ID="HP:0003225" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0020586" DB="MONDO" />
                <XRef ID="4320005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Reduced coagulation factor V activity</ElementValue>
                <XRef ID="HP:0003225" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Factor V Leiden thrombophilia is characterized by a poor anticoagulant response to activated protein C (APC) and an increased risk for venous thromboembolism (VTE). Deep vein thrombosis (DVT) is the most common VTE, with the legs being the most common site. Thrombosis in unusual locations is less common. Evidence suggests that heterozygosity for the Leiden variant has at most a modest effect on risk for recurrent thrombosis after initial treatment of a first VTE. It is unlikely that factor V Leiden thrombophilia (i.e., heterozygosity or homozygosity for the Leiden variant) is a major factor contributing to pregnancy loss and other adverse pregnancy outcomes (preeclampsia, fetal growth restriction, and placental abruption). The clinical expression of factor V Leiden thrombophilia is influenced by the following: The number of Leiden variants (heterozygotes have a slightly increased risk for venous thrombosis; homozygotes have a much greater thrombotic risk). Coexisting genetic thrombophilic disorders, which have a supra-additive effect on overall thrombotic risk. Acquired thrombophilic disorders: antiphospholipid antibody (APLA) syndrome, paroxysmal nocturnal hemoglobinuria, myeloproliferative disorders, and increased levels of clotting factors. Circumstantial risk factors including but not limited to pregnancy, central venous catheters, travel, combined oral contraceptive (COC) use and other combined contraceptives, oral hormone replacement therapy (HRT), selective estrogen receptor modulators (SERMs), obesity, leg injury, and advancing age.</Attribute>
                <XRef ID="NBK1368" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301542</ID>
                <ID Source="BookShelf">NBK1368</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2011">
                <ID Source="PubMed">21150787</ID>
              </Citation>
              <Citation Type="general" Abbrev="Retired, ACMG, 2001">
                <ID Source="pmc">3111091</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="ACMG, 2021">
                <ID Source="PubMed">33674767</ID>
              </Citation>
              <Citation Type="general" Abbrev="BSH, 2022">
                <ID Source="PubMed">35645034</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng158</URL>
                <CitationText>UK NICE Guideline NG158, Venous thromboembolic diseases: diagnosis, management and thrombophilia testing, 2023</CitationText>
              </Citation>
              <XRef ID="326" DB="Orphanet" />
              <XRef ID="C4317320" DB="MedGen" />
              <XRef ID="MONDO:0020586" DB="MONDO" />
              <XRef Type="primary" ID="HP:0003225" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20831" SubmissionDate="2017-08-17" DateLastUpdated="2017-08-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612309.0005_FACTOR V DEFICIENCY" title="F5, 4-BP INS, 2805ATTG_FACTOR V DEFICIENCY" />
        <ClinVarAccession Accession="SCV000020831" DateUpdated="2017-08-20" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Zehnder et al. (1999) identified a man with thrombophilia (188055) who was found to be compound heterozygous for factor V Leiden (612309.0001) and a null allele of the F5 gene resulting from a 4-bp insertion (2805insATTG) in exon 13. The insertion resulted in a frameshift and premature termination. The patient had 50% of normal levels of F5, all of which was of the Leiden type; hence he was 'pseudohomozygous' for factor V Leiden. Each of his 2 children inherited a different paternal factor V allele: the daughter was heterozygous for factor V Leiden, with 100% factor V activity, and the son was heterozygous for factor V deficiency, with 50% factor V activity and no factor V Leiden allele. The 4-bp insertion, designated factor V Stanford, was thus a factor V deficiency (227400) allele resulting in loss of protein function.</Attribute>
              <Citation>
                <ID Source="PubMed">10494770</ID>
              </Citation>
              <XRef DB="OMIM" ID="188055" Type="MIM" />
              <XRef DB="OMIM" ID="227400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F5" />
          </GeneList>
          <Name>F5, 4-BP INS, 2805ATTG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 2805ATTG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612309.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FACTOR V DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20831" TraitType="Disease" MappingType="Name" MappingValue="FACTOR V DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C4317320" Name="Factor V deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

